09:53 AM EST - BriaCell Therapeutics Corp. : Announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, a leading cancer center in Toronto, has joined BriaCell’s ongoing pivotal Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. BriaCell Therapeutics Corp.
shares T.BCT are trading down $0.12 at $5.40.
